Connor, Clark & Lunn Investment Management Ltd. Trans Medics Group, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 74,625 shares of TMDX stock, worth $6.01 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
74,625
Previous 9,753
665.15%
Holding current value
$6.01 Million
Previous $1.47 Million
698.09%
% of portfolio
0.06%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding TMDX
# of Institutions
394Shares Held
31.9MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$289 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$213 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$116 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$102 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$88.1 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.56B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...